Marc Blaustein - 13 Jun 2022 Form 4 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Role
Chief Operating Officer
Signature
By: /s/ Joseph Vittiglio, Attorney-in-Fact
Issuer symbol
FNCH
Transactions as of
13 Jun 2022
Net transactions value
$0
Form type
4
Filing time
15 Jun 2022, 17:06:00 UTC
Previous filing
28 Feb 2022
Next filing
25 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FNCH Common Stock Award $0 +35,000 +2800% $0.000000 36,250 13 Jun 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs"). One third (1/3) of the total number of RSUs granted vest on October 20, 2022, February 20, 2023 and June 20, 2023, subject to the Reporting Person's continued service on each applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
F2 Includes shares of common stock acquired through the Employee Stock Purchase Plan.